Manufacturing Partnership

RNS Number : 8243H
Ilika plc
20 November 2018
 

 

 

Ilika Plc

("Ilika" or the "Company")

 

Manufacturing Partnership  

Manufacturing agreement for Stereax® with Semefab Ltd

 

Ilika plc (AIM: IKA), the advanced solid-state battery technology and materials innovation company, announces an intended manufacturing partnership with Semefab Ltd ('Semefab') for the manufacture of Stereaxâ thin film solid-state cells.

 

Since 1986, Semefab has produced a diverse portfolio of CMOS, ASIC and semiconductor technologies. Ilika and Semefab have undertaken a detailed review of Ilika's qualified process for the manufacture of Stereaxâ thin film batteries. Semefab has confirmed that it has the microfabrication know-how to be able to manufacture Stereaxâ cells on an economic basis in quantities suitable for market introduction of products. Semefab has also confirmed that the Ilika process is technically compatible with its facility in Fife, Scotland.

 

Allan James, Semefab MD, stated: "We believe there is a substantial market opportunity for thin-film microfabricated batteries, which is well-aligned with our current business."

 

Graeme Purdy, Ilika CEO added: "We are delighted to be working with Semefab, which has a long history of manufacturing MEMS and IC products. Semefab is arguably currently the UK's leading commercial foundry of such devices. This key manufacturing partnership extends Ilika's market reach and advances the Company one step closer to a valuable licensing deal."

 

For more information on Semefab Ltd please visit: www.semefab.co.uk 

 

 

For more information contact:

 

Ilika plc

 

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director




Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan

Trystan Cullen, William Hall




Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABRBDBRXBBGIC

Companies

Ilika (IKA)
UK 100